Publication | Closed Access
A Randomized Controlled Clinical Trial to Evaluate the Efficacy, Safety, Cost-Effectiveness and Effect on PAI-1 Levels of the Three Low-Molecular-Weight Heparins – Enoxaparin, Nadroparin and Dalteparin
22
Citations
15
References
2006
Year
Any of the three LMWHs evaluated in this study were similar with respect to efficacy, safety, PAI-1 levels and cost-effectiveness.
| Year | Citations | |
|---|---|---|
Page 1
Page 1